Works matching IS 10837159 AND DT 2022 AND VI 27 AND IP 7

Results: 24

Time to Mammographic Density Decrease After Exposure to Tamoxifen.
Published in:
Oncologist, 2022, v. 27, n. 7, p. e601, doi. 10.1093/oncolo/oyac104
By:
- Bäcklund, Magnus;
- Eriksson, Mikael;
- Hammarström, Mattias;
- Thoren, Linda;
- Bergqvist, Jenny;
- Margolin, Sara;
- Hellgren, Roxanna;
- Wengström, Yvonne;
- Gabrielson, Marike;
- Czene, Kamila;
- Hall, Per
Publication type:
Article
Oncologist v2.0: Building on a 27-Year Legacy of Accomplishment.
Published in:
Oncologist, 2022, v. 27, n. 7, p. 517, doi. 10.1093/oncolo/oyac125
By:
- Bates, Susan E
Publication type:
Article
Topical Endoxifen for Mammographic Density Reduction—A Randomized Controlled Trial.
Published in:
Oncologist, 2022, v. 27, n. 7, p. e597, doi. 10.1093/oncolo/oyac102
By:
- Bäcklund, Magnus;
- Eriksson, Mikael;
- Gabrielson, Marike;
- Hammarström, Mattias;
- Quay, Steve;
- Bergqvist, Jenny;
- Hellgren, Roxanna;
- Czene, Kamila;
- Hall, Per
Publication type:
Article
Response to Nivolumab and Ipilimumab in Microsatellite Instability-High (MSI-H) Cervical Carcinoma with Acquired Resistance to Pembrolizumab: A Case Report and Literature Review.
Published in:
Oncologist, 2022, v. 27, n. 7, p. 525, doi. 10.1093/oncolo/oyac095
By:
- Gim, Gahyun;
- Kim, Yeseul;
- Park, Yeonggyeong;
- Kim, Min Jeong;
- Nam, Myungwoo;
- Yang, Woojung;
- Duarte, Samantha E;
- Jung, Chan Mi;
- Vagia, Elena;
- Viveiros, Pedro;
- Chae, Young Kwang
Publication type:
Article
In Reply: TP53 Alteration Status and Tumor Mutational Burden Score: Prevalence and Prognosis in Head and Neck Squamous Cell Carcinoma.
Published in:
Oncologist, 2022, v. 27, n. 7, p. e606, doi. 10.1093/oncolo/oyac088
By:
- Burcher, Kimberly M;
- Wilson, Harper L;
- Gavrila, Elena;
- Abreu, Arianne;
- D'Agostino, Ralph B;
- Zhang, Wei;
- Porosnicu, Mercedes
Publication type:
Article
Prognostic Value of TP53 Alteration in Patients with Head and Neck Squamous Cell Carcinoma Receiving Immunotherapy.
Published in:
Oncologist, 2022, v. 27, n. 7, p. e604, doi. 10.1093/oncolo/oyac087
By:
- Jiang, Chao;
- Zhou, Xuanchen;
- Han, Jie;
- Yue, Zhiyong;
- Li, Butuo
Publication type:
Article
Association Between Lifestyle Changes, Mammographic Breast Density, and Breast Cancer.
Published in:
Oncologist, 2022, v. 27, n. 7, p. 548, doi. 10.1093/oncolo/oyac084
By:
- Lester, Sara P;
- Kaur, Aparna S;
- Vegunta, Suneela
Publication type:
Article
Phase II Study of Cabozantinib in Patients With Bone Metastasis.
Published in:
Oncologist, 2022, v. 27, n. 7, p. 600, doi. 10.1093/oncolo/oyac083
By:
- Choy, Edwin;
- Cote, Gregory M;
- Michaelson, M Dror;
- Wirth, Lori;
- Gainor, Justin F;
- Muzikansky, Alona;
- Sequist, Lecia V;
- Sullivan, Ryan J;
- Fidias, Panagiotis M;
- Shaw, Alice;
- Heist, Rebecca S
Publication type:
Article
Developing a Virtual Equity Hub: Adapting the Tumor Board Model for Equity in Cancer Care.
Published in:
Oncologist, 2022, v. 27, n. 7, p. 518, doi. 10.1093/oncolo/oyac069
By:
- Irwin, Kelly E;
- Ko, Naomi;
- Walsh, Elizabeth P;
- Decker, Veronica;
- Arrillaga-Romany, Isabel;
- Plotkin, Scott R;
- Franas, Jeffrey;
- Gorton, Emily;
- Moy, Beverly
Publication type:
Article
Daratumumab Improves Depth of Response and Progression-free Survival in Transplant-ineligible, High-risk, Newly Diagnosed Multiple Myeloma.
Published in:
Oncologist, 2022, v. 27, n. 7, p. e589, doi. 10.1093/oncolo/oyac067
By:
- Jakubowiak, Andrzej J;
- Kumar, Shaji;
- Medhekar, Rohan;
- Pei, Huiling;
- Lefebvre, Patrick;
- Kaila, Shuchita;
- He, Jianming;
- Lafeuille, Marie-Hélène;
- Cortoos, Annelore;
- Londhe, Anil;
- Mavros, Panagiotis;
- Lin, Thomas S;
- Usmani, Saad Z
Publication type:
Article
Giant Cell Tumor of Bone: Effect of Longer Dosing Intervals of Denosumab on Tumor Control and Bone-related Complications.
Published in:
Oncologist, 2022, v. 27, n. 7, p. 595, doi. 10.1093/oncolo/oyac066
By:
- Jiang, Cindy Y;
- Zhao, Lili;
- Schuetze, Scott M;
- Chugh, Rashmi
Publication type:
Article
Lenvatinib for the Treatment of Radioiodine-Refractory Differentiated Thyroid Cancer: Treatment Optimization for Maximum Clinical Benefit.
Published in:
Oncologist, 2022, v. 27, n. 7, p. 565, doi. 10.1093/oncolo/oyac065
By:
- Wirth, Lori J;
- Durante, Cosimo;
- Topliss, Duncan J;
- Winquist, Eric;
- Robenshtok, Eyal;
- Iwasaki, Hiroyuki;
- Luster, Markus;
- Elisei, Rossella;
- Leboulleux, Sophie;
- Tahara, Makoto
Publication type:
Article
Immune Checkpoint Inhibitors in the Treatment of Breast Cancer Brain Metastases.
Published in:
Oncologist, 2022, v. 27, n. 7, p. 538, doi. 10.1093/oncolo/oyac064
By:
- Schlam, Ilana;
- Gatti-Mays, Margaret E
Publication type:
Article
Impact of G-CSF Prophylaxis on Chemotherapy Dose-Intensity, Link Between Dose-Intensity and Survival in Patients with Metastatic Pancreatic Adenocarcinoma.
Published in:
Oncologist, 2022, v. 27, n. 7, p. e571, doi. 10.1093/oncolo/oyac055
By:
- Canton, Clémence;
- Boussari, Olayidé;
- Boulin, Mathieu;
- Malicot, Karine Le;
- Taieb, Julien;
- Dahan, Laetitia;
- Lopez, Anthony;
- Lepage, Come;
- Bachet, Jean-Baptiste
Publication type:
Article
FDA Approval Summary: Axicabtagene Ciloleucel for Relapsed or Refractory Follicular Lymphoma.
Published in:
Oncologist, 2022, v. 27, n. 7, p. 587, doi. 10.1093/oncolo/oyac054
By:
- Bouchkouj, Najat;
- Zimmerman, Megan;
- Kasamon, Yvette L;
- Wang, Cong;
- Dai, Tianjiao;
- Xu, Zhenzhen;
- Wang, Xiaofei;
- Theoret, Marc;
- Purohit-Sheth, Tejashri;
- George, Bindu
Publication type:
Article
Polypharmacy, Potentially Inappropriate Medications, and Drug-Drug Interactions in Vulnerable Older Adults With Advanced Cancer Initiating Cancer Treatment.
Published in:
Oncologist, 2022, v. 27, n. 7, p. e580, doi. 10.1093/oncolo/oyac053
By:
- Ramsdale, Erika;
- Mohamed, Mostafa;
- Yu, Veronica;
- Otto, Ethan;
- Juba, Katherine;
- Awad, Hala;
- Moorthi, Kiran;
- Plumb, Sandy;
- Patil, Amita;
- Vogelzang, Nicholas;
- Dib, Elie;
- Mohile, Supriya
Publication type:
Article
Fertility Preservation Discussions Between Young Adult Rectal Cancer Survivors and Their Providers: Sex-Specific Prevalence and Correlates.
Published in:
Oncologist, 2022, v. 27, n. 7, p. 579, doi. 10.1093/oncolo/oyac052
By:
- Stal, Julia;
- Yi, Serena Y;
- Cohen-Cutler, Sally;
- Gallagher, Phuong;
- Barzi, Afsaneh;
- Freyer, David R;
- Milam, Joel E;
- Lenz, Heinz-Josef;
- Miller, Kimberly A
Publication type:
Article
Survival and Incidence Patterns of Pancreatic Neuroendocrine Tumors Over the Last 2 Decades: A SEER Database Analysis.
Published in:
Oncologist, 2022, v. 27, n. 7, p. 573, doi. 10.1093/oncolo/oyac049
By:
- Sonbol, Mohamad Bassam;
- Mazza, Gina L;
- Mi, Lanyu;
- Oliver, Thomas;
- Starr, Jason;
- Gudmundsdottir, Hallbera;
- Cleary, Sean P;
- Hobday, Timothy;
- Halfdanarson, Thorvardur R
Publication type:
Article
Inequity in Telemedicine Use Among Patients with Cancer in the Deep South During the COVID-19 Pandemic.
Published in:
Oncologist, 2022, v. 27, n. 7, p. 555, doi. 10.1093/oncolo/oyac046
By:
- Shao, Connie C;
- McLeod, M Chandler;
- Gleason, Lauren T;
- Marques, Isabel C Dos Santos;
- Chu, Daniel I;
- Wallace, Eric L;
- Fouad, Mona N;
- Reddy, Sushanth
Publication type:
Article
Modeling the Prognostic Impact of Circulating Tumor Cells Enumeration in Metastatic Breast Cancer for Clinical Trial Design Simulation.
Published in:
Oncologist, 2022, v. 27, n. 7, p. e561, doi. 10.1093/oncolo/oyac045
By:
- Gerratana, Lorenzo;
- Pierga, Jean-Yves;
- Reuben, James M;
- Davis, Andrew A;
- Wehbe, Firas H;
- Dirix, Luc;
- Fehm, Tanja;
- Nolé, Franco;
- Gisbert-Criado, Rafael;
- Mavroudis, Dimitrios;
- Grisanti, Salvatore;
- Garcia-Saenz, Jose A;
- Stebbing, Justin;
- Caldas, Carlos;
- Gazzaniga, Paola;
- Manso, Luis;
- Zamarchi, Rita;
- Bonotto, Marta;
- Lascoiti, Angela Fernandez de;
- Mattos-Arruda, Leticia De
Publication type:
Article
N064A (Alliance): Phase II Study of Panitumumab, Chemotherapy, and External Beam Radiation in Patients with Locally Advanced Pancreatic Adenocarcinoma.
Published in:
Oncologist, 2022, v. 27, n. 7, p. 534, doi. 10.1093/oncolo/oyac002
By:
- Halfdanarson, Thorvardur R;
- Foster, Nathan R;
- Kim, George P;
- Haddock, Michael G;
- Dakhil, Shaker R;
- Behrens, Robert J;
- Alberts, Steven R
Publication type:
Article
Phase I Study of JNJ-74699157 in Patients with Advanced Solid Tumors Harboring the KRAS G12C Mutation.
Published in:
Oncologist, 2022, v. 27, n. 7, p. 536, doi. 10.1093/oncolo/oyab080
By:
- Wang, Judy;
- Martin-Romano, Patricia;
- Cassier, Philippe;
- Johnson, Melissa;
- Haura, Eric;
- Lenox, Laurie;
- Guo, Yue;
- Bandyopadhyay, Nibedita;
- Russell, Michael;
- Shearin, Elizabeth;
- Lauring, Josh;
- Dahan, Laetitia
Publication type:
Article
Vincristine Sulfate Liposome Injection with Bendamustine and Rituximab as First-Line Therapy for B-Cell Lymphomas: A Phase I Study.
Published in:
Oncologist, 2022, v. 27, n. 7, p. 532, doi. 10.1093/oncolo/oyab079
By:
- Ollila, Thomas;
- Butera, James;
- Egan, Pamela;
- Reagan, John;
- Thomas, Anthony;
- Yakirevich, Inna;
- MacKinnon, Kelsey;
- Margolis, Jeannine;
- McMahon, Jessica;
- Rosati, Valerie;
- Olszewski, Adam J
Publication type:
Article
Prevention of Pemetrexed-Induced Rash Using Low-Dose Corticosteroids: A Phase II Study.
Published in:
Oncologist, 2022, v. 27, n. 7, p. e554, doi. 10.1093/oncolo/oyab077
By:
- Sakurada, Takumi;
- Nokihara, Hiroshi;
- Koga, Tadashi;
- Zamami, Yoshito;
- Goda, Mitsuhiro;
- Yagi, Kenta;
- Hamano, Hirofumi;
- Aizawa, Fuka;
- Ogino, Hirokazu;
- Sato, Seidai;
- Kirino, Yasushi;
- Goto, Hisatsugu;
- Nishioka, Yasuhiko;
- Ishizawa, Keisuke
Publication type:
Article